Evidence map›Paper›PMID 40673144›Full record

ReviewFrontiers in microbiology2025

Efficient biodegradation and upcycling of polyethylene terephthalate mediated by cell-factories.

Fei Liu, Tao Wang, Xiao-Huan Liu, Na Xu, Xing-Li Pan

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fei Liu *School of Life Sciences, Jining Medical University, Jining, China.
Tao Wang *School of Life Sciences, Jining Medical University, Jining, China.
Xiao-Huan LiuSchool of Life Sciences, Jining Medical University, Jining, China.
Na XuSchool of Pharmacy/School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Xing-Li PanSchool of Life Sciences, Jining Medical University, Jining, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pervasive accumulation of polyethylene terephthalate (PET) waste has emerged as a critical ecological crisis, which is mainly driven by its recalcitrance to natural degradation and widespread contamination of terrestrial and aquatic ecosystems. In response to this challenge, microbial-mediated PET biodegradation has garnered significant scientific attentions as a sustainable remediation strategy, harnessing the enzymatic cascades of specialized microorganisms to depolymerize PET into bio-assimilable monomers such as terephthalic acid (TPA) and ethylene glycol (EG). In this review, we summarize the extracellular process of PET biodegradation, including microbial attachment, colonization, and direct depolymerization, as well as the metabolic pathways of PET monomers. Strategies for developing PET-degrading chassis cells are also discussed, such as cell surface display, metabolic pathway optimization, and rational design of enzyme-PET interfaces. Microbial-enzyme consortia and molecular engineering of photosynthetic microorganisms also contribute to PET degradation. Although significant progress has been made, challenges remain in enzyme stability, metabolic bottlenecks, industrial scalability, and environmental adaptation. Overall, microbial and enzymatic strategies show great potentials in addressing PET pollution, and future interdisciplinary efforts are needed to overcome these challenges and achieve a sustainable circular plastic economy.

Indexed as

cell factorymetabolic engineeringmicrobial degradationPET recyclingpolyethylene terephthalatesynthetic biology

Identifiers

PMID40673144
PMCPMC12263691

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.